|
ES2289116T3
(es)
*
|
2001-05-24 |
2008-02-01 |
Eli Lilly And Company |
Nuevos derivados de pirrol como agentes farmaceuticos.
|
|
ES2292839T3
(es)
*
|
2001-12-11 |
2008-03-16 |
Smithkline Beecham Corporation |
Derivados de pirazolo-piridina como agentes contra el herpes.
|
|
EP1543001B1
(en)
*
|
2002-09-17 |
2007-08-15 |
Eli Lilly And Company |
Pyrazolopyridine derivatives as tgf beta signal transduction inhibitors for the treatment of cancer
|
|
CA2506799A1
(en)
*
|
2002-11-21 |
2004-06-10 |
Eli Lilly And Company |
Mixed lineage kinase modulators
|
|
WO2004048381A2
(en)
*
|
2002-11-22 |
2004-06-10 |
Eli Lilly And Company |
Pyrazoloazepine compounds as pharmaceutical agents
|
|
UA80571C2
(en)
*
|
2002-11-22 |
2007-10-10 |
Lilly Co Eli |
Quinolinyl-pyrrolopyrazoles
|
|
AU2003290734A1
(en)
*
|
2002-11-27 |
2004-06-23 |
Eli Lilly And Company |
Novel compounds as pharmaceutical agents
|
|
CL2004000234A1
(es)
*
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
|
US7511065B2
(en)
*
|
2003-11-12 |
2009-03-31 |
Eli Lilly And Company |
Mixed lineage kinase modulators
|
|
EP1723146A1
(en)
*
|
2004-03-01 |
2006-11-22 |
Eli Lilly And Company |
Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms
|
|
TW200639163A
(en)
*
|
2005-02-04 |
2006-11-16 |
Genentech Inc |
RAF inhibitor compounds and methods
|
|
AU2006228683B2
(en)
|
2005-04-01 |
2012-02-02 |
Vfp Therapies |
New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-Alzheimer agents
|
|
SI1910370T1
(sl)
*
|
2005-07-22 |
2015-06-30 |
Eli Lilly And Company |
Piridin kinolin substituirani pirolo(1,2-b)pirazol monohidrat kot tgf-beta inhibitor
|
|
WO2007021966A1
(en)
|
2005-08-12 |
2007-02-22 |
Synta Pharmaceuticals Corp. |
Pyrazole compounds that modulate hsp90 activity
|
|
WO2007076127A2
(en)
*
|
2005-12-22 |
2007-07-05 |
Biogen Idec Ma Inc |
Condensed imidazoles or pyrazoles and their use as transforming growth factor modulators
|
|
DE102005061840A1
(de)
|
2005-12-23 |
2007-06-28 |
Merck Patent Gmbh |
Triazolderivate
|
|
US8034834B2
(en)
|
2006-05-25 |
2011-10-11 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders with HSP90 inhibitors
|
|
DK2918288T3
(da)
|
2006-10-03 |
2017-11-27 |
Genzyme Corp |
Anvendelse af TGF-beta-antagonister til behandling af spædbørn med risiko for udvikling af bronkopulmonal dysplasi
|
|
PE20090717A1
(es)
*
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
ES2398677T3
(es)
*
|
2007-12-12 |
2013-03-20 |
E. I. Du Pont De Nemours And Company |
Pirazoles bicíclicos fungicidas
|
|
EP2373664B1
(en)
*
|
2008-12-19 |
2013-06-12 |
Nerviano Medical Sciences S.r.l. |
Bicyclic pyrazoles as protein kinase inhibitors
|
|
EP2419105A4
(en)
*
|
2009-04-17 |
2012-09-12 |
Summa Health Systems Llc |
USE OF TRANSFORMATION OF GROWTH FACTOR B RECEPTOR INHIBITORS TO SUPPRESS OCULAR HEALING
|
|
AR081810A1
(es)
*
|
2010-04-07 |
2012-10-24 |
Bayer Cropscience Ag |
Piridinilpirazoles biciclicos
|
|
EP2560640A1
(en)
|
2010-04-19 |
2013-02-27 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of a hsp90 inhibitory compounds and a egfr inhibitor
|
|
EP2402339A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazolopyridine compounds
|
|
EP2402337A1
(en)
*
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazolopyridine compounds
|
|
EP2401915A1
(en)
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazolopyridine compounds
|
|
EP2402340A1
(en)
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazolopyridine compounds
|
|
EP2402338A1
(en)
|
2010-06-29 |
2012-01-04 |
Basf Se |
Pyrazolopyridine compounds
|
|
US8871744B2
(en)
|
2010-07-21 |
2014-10-28 |
B & G Partyers, LLC |
Compounds and methods for selectively targeting tumor-associated mucins
|
|
WO2012138945A1
(en)
|
2011-04-08 |
2012-10-11 |
Aestus Therapeutics, Inc. |
Methods of treating schizophrenia with pyrazole derivative inhibitors of tgf - beta
|
|
WO2013014262A1
(en)
|
2011-07-27 |
2013-01-31 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for diagnosing and treating myhre syndrome
|
|
BR112014009789A2
(pt)
|
2011-10-26 |
2017-04-25 |
Seattle Children's Res Inst |
cisteamina no tratamento da doença fibrótica
|
|
CA2853799A1
(en)
|
2011-11-02 |
2013-05-10 |
Synta Pharmaceuticals Corp. |
Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
|
|
AU2012332424A1
(en)
|
2011-11-02 |
2014-06-05 |
Synta Pharmaceuticals Corp. |
Combination therapy of Hsp90 inhibitors with platinum-containing agents
|
|
WO2013074594A1
(en)
|
2011-11-14 |
2013-05-23 |
Synta Pharmaceuticals Corp. |
Combination therapy of hsp90 inhibitors with braf inhibitors
|
|
US9782452B2
(en)
|
2011-11-22 |
2017-10-10 |
Cornell University |
Methods for stimulating hematopoietic recovery by inhibiting TGFβ signaling
|
|
ES2966030T3
(es)
|
2012-10-05 |
2024-04-18 |
Kadmon Corp Llc |
Anticuerpos anti-VEGFR-2/KDR humanos
|
|
TWI443096B
(zh)
|
2012-12-18 |
2014-07-01 |
Ind Tech Res Inst |
３－（５－（４－（３－氟丙基）哌嗪－１－基）苯並咪唑－２－基）－１－氮雜薁－２－酮之單水合晶型及其製備方法與藥學組成物
|
|
JP2016507537A
(ja)
*
|
2013-02-07 |
2016-03-10 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ |
置換アセチレン誘導体およびｍＧｌｕＲ４の正のアロステリックモジュレーターとしてのそれらの使用
|
|
CA3184040A1
(en)
|
2013-03-14 |
2014-10-02 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods for epithelial stem cell expansion comprising a wnt agonist and a histone deacetylase inhibitor
|
|
US8975417B2
(en)
*
|
2013-05-27 |
2015-03-10 |
Novartis Ag |
Pyrazolopyrrolidine derivatives and their use in the treatment of disease
|
|
KR102408261B1
(ko)
|
2014-02-03 |
2022-06-10 |
비타이 파마슈티컬즈, 엘엘씨 |
Ror-감마의 디하이드로피롤로피리딘 저해제
|
|
WO2016037016A1
(en)
|
2014-09-03 |
2016-03-10 |
The Brigham And Women's Hospital, Inc. |
Compositions, systems, and methods for generating inner ear hair cells for treatment of hearing loss
|
|
JO3336B1
(ar)
|
2014-10-07 |
2019-03-13 |
Lilly Co Eli |
مركبات أمينو بيريديلوكسي بيرازول
|
|
US9663515B2
(en)
|
2014-11-05 |
2017-05-30 |
Vitae Pharmaceuticals, Inc. |
Dihydropyrrolopyridine inhibitors of ROR-gamma
|
|
EP3277673B1
(en)
|
2015-04-01 |
2022-05-04 |
Rigel Pharmaceuticals, Inc. |
Tgf-beta inhibitors
|
|
EP3313420B1
(en)
|
2015-06-25 |
2024-03-13 |
The Children's Medical Center Corporation |
Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
|
|
US10301261B2
(en)
|
2015-08-05 |
2019-05-28 |
Vitae Pharmaceuticals, Llc |
Substituted indoles as modulators of ROR-gamma
|
|
EP3868750A1
(en)
|
2015-11-20 |
2021-08-25 |
Vitae Pharmaceuticals, LLC |
Modulators of ror-gamma
|
|
AU2017205194A1
(en)
|
2016-01-08 |
2018-07-19 |
Massachusetts Institute Of Technology |
Production of differentiated enteroendocrine cells and insulin producing cells
|
|
TWI757266B
(zh)
|
2016-01-29 |
2022-03-11 |
美商維它藥物有限責任公司 |
ＲＯＲ－γ調節劑
|
|
US10213511B2
(en)
|
2016-03-02 |
2019-02-26 |
Frequency Therapeutics, Inc. |
Thermoreversible compositions for administration of therapeutic agents
|
|
US10201540B2
(en)
|
2016-03-02 |
2019-02-12 |
Frequency Therapeutics, Inc. |
Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using GSK3 inhibitors: I
|
|
US11260130B2
(en)
|
2016-03-02 |
2022-03-01 |
Frequency Therapeutics, Inc. |
Solubilized compositions for controlled proliferation of stem cells / generating inner ear hair cells using a GSK3 inhibitor: IV
|
|
DK3429603T3
(da)
|
2016-03-15 |
2022-03-14 |
Childrens Medical Center |
Fremgangsmåder og sammensætninger vedrørende ekspansion af hæmatopoietiske stamceller
|
|
RU2737737C2
(ru)
*
|
2016-06-13 |
2020-12-02 |
Джинфлит Терапьютикс (Шанхай) Инк. |
АЛЬФА- И БЕТА-НЕНАСЫЩЕННОЕ АМИДНОЕ СОЕДИНЕНИЕ - ПРОИЗВОДНОЕ БЕНЗОТРИАЗОЛА, ПРИМЕНЯЕМОЕ В КАЧЕСТВЕ ИНГИБИТОРА TGF-βRI
|
|
KR102365333B1
(ko)
|
2016-07-29 |
2022-02-23 |
상하이 잉리 파마슈티컬 컴퍼니 리미티드 |
질소 함유 방향족 헤테로 고리 화합물, 이의 제조 방법, 약물 조성물 및 응용
|
|
CN110392686A
(zh)
|
2016-12-30 |
2019-10-29 |
频率治疗公司 |
1h-吡咯-2,5-二酮化合物以及使用它们来诱导干/祖支持细胞自我更新的方法
|
|
PL3618829T3
(pl)
*
|
2017-05-05 |
2023-11-20 |
Arcus Biosciences, Inc. |
Pochodne chinazolinopirydyny do leczenia zaburzeń związanych z nowotworem
|
|
WO2019018975A1
(en)
|
2017-07-24 |
2019-01-31 |
Vitae Pharmaceuticals, Inc. |
INHIBITORS OF ROR GAMMA
|
|
CN111225914B
(zh)
|
2017-07-24 |
2022-10-11 |
生命医药有限责任公司 |
RORγ的抑制剂
|
|
US10342786B2
(en)
|
2017-10-05 |
2019-07-09 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
|
|
PT3691620T
(pt)
|
2017-10-05 |
2022-10-06 |
Fulcrum Therapeutics Inc |
Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
|
|
AU2018348930A1
(en)
|
2017-10-11 |
2020-03-26 |
F. Hoffmann-La Roche Ag |
Bicyclic compounds for use as RIP 1 kinase inhibitors
|
|
JP2021035911A
(ja)
*
|
2017-11-15 |
2021-03-04 |
大日本住友製薬株式会社 |
縮環ピラゾール誘導体及びその医薬用途
|
|
CN111479809B
(zh)
|
2017-12-13 |
2021-10-29 |
劲方医药科技(上海)有限公司 |
一种TGF-βRI抑制剂的晶型、盐型及其制备方法
|
|
CN110066276B
(zh)
|
2018-01-24 |
2020-09-18 |
上海璎黎药业有限公司 |
芳香杂环化合物、其中间体、制备方法、药物组合物和应用
|
|
CN110066277B
(zh)
|
2018-01-24 |
2021-07-23 |
上海璎黎药业有限公司 |
芳香杂环取代烯烃化合物、其制备方法、药物组合物和应用
|
|
WO2019183245A1
(en)
|
2018-03-20 |
2019-09-26 |
Icahn School Of Medicine At Mount Sinai |
Kinase inhibitor compounds and compositions and methods of use
|
|
US20210254006A1
(en)
|
2018-06-06 |
2021-08-19 |
Ideaya Biosciences, Inc. |
Methods of culturing and/or expanding stem cells and/or lineage committed progenitor cells using lactam compounds
|
|
CN112867724B
(zh)
*
|
2018-07-23 |
2024-06-04 |
熙源安健医药(北京)有限公司 |
二膦酸盐药物缀合物
|
|
WO2020037326A1
(en)
|
2018-08-17 |
2020-02-20 |
Frequency Therapeutics, Inc. |
Compositions and methods for generating hair cells by downregulating foxo
|
|
US11162071B2
(en)
|
2018-08-17 |
2021-11-02 |
Frequency Therapeutics, Inc. |
Compositions and methods for generating hair cells by upregulating JAG-1
|
|
KR102126576B1
(ko)
|
2018-09-19 |
2020-06-24 |
주식회사 대웅제약 |
4-메톡시 피롤 유도체의 제조 방법
|
|
WO2020088526A1
(zh)
*
|
2018-10-31 |
2020-05-07 |
南京明德新药研发有限公司 |
作为TGF-βR1激酶抑制剂的双环吡唑类化合物
|
|
CN113347965B
(zh)
*
|
2018-11-22 |
2025-02-18 |
生物医学研究机构基金会 |
TGFβ抑制剂和前药
|
|
AU2019417418B2
(en)
|
2018-12-27 |
2025-02-27 |
Nexys Therapeutics, Inc. |
(pyridin-2-yl)amine derivatives as ΤGFβR1 (Alk5) inhibitors for the treatment of cancer
|
|
AU2019419414A1
(en)
|
2018-12-31 |
2023-04-06 |
Icahn School Of Medicine At Mount Sinai |
Kinase inhibitor compounds and compositions and methods of use
|
|
JP7331116B2
(ja)
*
|
2019-01-24 |
2023-08-22 |
チアンスー アオサイカン ファーマシューティカル カンパニー，リミティド |
ＴＧＦ－βＲ１キナーゼ阻害剤としての５－（４－ピリジルオキシ）ピラゾール類化合物
|
|
WO2020160151A1
(en)
*
|
2019-01-31 |
2020-08-06 |
Kyorin Pharmaceutical Co., Ltd. |
15-pgdh inhibitors
|
|
US20220177978A1
(en)
|
2019-04-02 |
2022-06-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of predicting and preventing cancer in patients having premalignant lesions
|
|
CN113557236B
(zh)
*
|
2019-06-10 |
2022-05-10 |
中国科学院广州生物医药与健康研究院 |
一种双功能免疫调节剂及其在药学上可接受的盐、药物组合物
|
|
WO2021142086A1
(en)
|
2020-01-08 |
2021-07-15 |
Synthis Therapeutics, Inc. |
Alk5 inhibitor conjugates and uses thereof
|
|
CN114867723B
(zh)
*
|
2020-07-23 |
2023-05-30 |
江苏奥赛康药业有限公司 |
作为TGF-βR1抑制剂的吡啶氧基连吡唑类化合物的盐型、晶型以及其药物组合物
|
|
CN116249692B
(zh)
|
2020-09-28 |
2024-08-23 |
四川科伦博泰生物医药股份有限公司 |
吡唑类化合物及其制备方法和用途
|
|
CN114437082B
(zh)
*
|
2020-11-06 |
2025-04-04 |
江苏先声药业有限公司 |
喹啉类化合物
|
|
CN115703750B
(zh)
*
|
2021-08-17 |
2024-07-02 |
黑龙江华瑞生物科技有限公司 |
一种1-氨基-4-甲基哌嗪的提取纯化方法
|
|
CN114249742B
(zh)
*
|
2021-11-22 |
2022-11-01 |
郑州大学 |
一种光气探针、荧光书写检测笔及其在光气检测中的应用
|
|
CN115969801B
(zh)
*
|
2023-03-21 |
2023-08-25 |
劲方医药科技(上海)有限公司 |
用于癌症的药物组合物及其制备方法
|
|
WO2024258967A1
(en)
|
2023-06-13 |
2024-12-19 |
Synthis Therapeutics, Inc. |
Anti-cd5 antibodies and their uses
|
|
GB202309553D0
(en)
|
2023-06-24 |
2023-08-09 |
Ucl Business Ltd |
Compostions and uses thereof
|
|
CN118652155A
(zh)
*
|
2024-06-17 |
2024-09-17 |
南京工业大学 |
一种二芳基乙炔的合成方法
|